Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human Arboviral Infections in Italy: Past, Current, and Future Challenges.
Rossi B, Barreca F, Benvenuto D, Braccialarghe N, Campogiani L, Lodi A, Aguglia C, Cavasio RA, Giacalone ML, Kontogiannis D, Moccione M, Malagnino V, Andreoni M, Sarmati L, Iannetta M. Rossi B, et al. Among authors: lodi a. Viruses. 2023 Jan 27;15(2):368. doi: 10.3390/v15020368. Viruses. 2023. PMID: 36851582 Free PMC article. Review.
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
Severa M, Diotti RA, Etna MP, Rizzo F, Fiore S, Ricci D, Iannetta M, Sinigaglia A, Lodi A, Mancini N, Criscuolo E, Clementi M, Andreoni M, Balducci S, Barzon L, Stefanelli P, Clementi N, Coccia EM. Severa M, et al. Among authors: lodi a. PLoS Pathog. 2021 Sep 2;17(9):e1009878. doi: 10.1371/journal.ppat.1009878. eCollection 2021 Sep. PLoS Pathog. 2021. PMID: 34473805 Free PMC article.
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production.
Imeneo A, Alessio G, Di Lorenzo A, Campogiani L, Lodi A, Barreca F, Zordan M, Barchi V, Massa B, Tedde S, Crea A, Vitale P, Spalliera I, Compagno M, Coppola L, Dori L, Malagnino V, Teti E, Andreoni M, Sarmati L, Iannetta M. Imeneo A, et al. Among authors: lodi a. Life (Basel). 2022 Feb 7;12(2):244. doi: 10.3390/life12020244. Life (Basel). 2022. PMID: 35207531 Free PMC article.
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients.
Di Lorenzo A, Tedde S, Pace PG, Campogiani L, Ansaldo L, Lodi A, Zordan M, Barreca F, Caldara F, Rossi B, Imeneo A, Alessio G, Crea AMA, Checchi D, Malagnino V, Teti E, Coppola L, Palmieri R, Buccisano F, Andreoni M, Sarmati L, Iannetta M. Di Lorenzo A, et al. Among authors: lodi a. Biomedicines. 2022 Nov 2;10(11):2788. doi: 10.3390/biomedicines10112788. Biomedicines. 2022. PMID: 36359306 Free PMC article.
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study.
Campogiani L, Vitale P, Lodi A, Imeneo A, Fontana C, D'Agostini C, Compagno M, Coppola L, Spalliera I, Malagnino V, Teti E, Iannetta M, Andreoni M, Sarmati L. Campogiani L, et al. Among authors: lodi a. Antibiotics (Basel). 2023 Apr 27;12(5):820. doi: 10.3390/antibiotics12050820. Antibiotics (Basel). 2023. PMID: 37237722 Free PMC article.
Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study.
Oliva A, Campogiani L, Savelloni G, Vitale P, Lodi A, Sacco F, Imeneo A, Volpicelli L, Polani R, Raponi G, Sarmati L, Venditti M. Oliva A, et al. Among authors: lodi a. Open Forum Infect Dis. 2023 Jun 30;10(7):ofad327. doi: 10.1093/ofid/ofad327. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37476077 Free PMC article.
Daptomycin-induced eosinophilic pneumonia: a case report and systematic review.
Di Lorenzo A, Rindi LV, Campogiani L, Imeneo A, Alessio G, Pace PG, Lodi A, Rossi B, Crea AMA, Vitale P, Kontogiannis D, Malagnino V, Andreoni M, Iannetta M, Sarmati L. Di Lorenzo A, et al. Among authors: lodi a. Chemotherapy. 2023 Nov 14. doi: 10.1159/000535190. Online ahead of print. Chemotherapy. 2023. PMID: 37963447
Porphyrin-fused graphene nanoribbons.
Chen Q, Lodi A, Zhang H, Gee A, Wang HI, Kong F, Clarke M, Edmondson M, Hart J, O'Shea JN, Stawski W, Baugh J, Narita A, Saywell A, Bonn M, Müllen K, Bogani L, Anderson HL. Chen Q, et al. Among authors: lodi a. Nat Chem. 2024 Mar 8. doi: 10.1038/s41557-024-01477-1. Online ahead of print. Nat Chem. 2024. PMID: 38459234
Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy.
Stanford SM, Nguyen TP, Chang J, Zhao Z, Hackman GL, Santelli E, Sanders CM, Katiki M, Dondossola E, Brauer BL, Diaz MA, Zhan Y, Ramsey SH, Watson PA, Sankaran B, Paindelli C, Parietti V, Mikos AG, Lodi A, Bagrodia A, Elliott A, McKay RR, Murali R, Tiziani S, Kettenbach AN, Bottini N. Stanford SM, et al. Among authors: lodi a. Sci Adv. 2024 Feb 2;10(5):eadg7887. doi: 10.1126/sciadv.adg7887. Epub 2024 Jan 31. Sci Adv. 2024. PMID: 38295166 Free PMC article.
228 results